ANURAS2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member ANURAS2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member ANURAS2022-10-012022-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ANURAS2022-10-012022-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ANURAS2022-10-012022-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ANURAS2022-10-012022-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ANURAS2022-10-012022-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member ANURAS2022-10-012022-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member ANURAS2022-10-012022-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member ANURAS2022-10-012022-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares ANURAS 2022-04-01 2023-03-31 2023-01-20 INR Millions Third quarter Single segment The group operates only in the one revenue segment. i.e. Manufacturing of industrial chemicals. 2022-10-01 2022-12-31 Unaudited Consolidated 3827446000.00 60430000.00 3887876000.00 1548350000.00 0.00 135753000.00 200327000.00 141619000.00 184835000.00 923674000.00 3134558000.00 753318000.00 0.00 753318000.00 168659000.00 40573000.00 209232000.00 0.00 544086000.00 0.00 0.00 0.00 225000.00 544311000.00 -2626000.00 541685000.00 429128000.00 115183000.00 426502000.00 115183000.00 1072068000.00 10 5.31 5.30 0.00 0.00 5.31 5.30 Notes: [1] The above consolidated financial results for the quarter and nine months ended December 31, 2022 have been prepared by the Company in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) and were reviewed by the Audit Committee of the Board and thereafter were approved and taken on record by the Board of Directors in their meeting held on January 27, 2023. An interim review of the above results has been carried out by the statutory auditors of the Company. [2] Based on the management approach as defined in Ind AS 108 - Operating Segments, the Chief Operating Decision Maker (CODM) evaluates the Company's performance and allocates resources based on an analysis of various performance indicators of business segment/s in which the Company operates. The Company is primarily engaged in the business of custom synthesis and manufacturing of specialty chemicals which the management and CODM recognise as the sole business segment. Hence, disclosure of segment-wise information is not required and accordingly not provided. [3] A fire broke out at one of the manufacturing plants of the Company located at Sachin, Gujarat in September, 2022. The Company has made primary assessment of the physical damage and financial impact owing to the fire and lodged claims with the insurance company. During the quarter and nine months ending on December 31, 2022, an impairment test has been carried out based on the primary assessment of inventory and Property, plant and equipment damaged due to fire and the same has been given effect to the financial statements. The Company, being eligible for the replaceable amount of the assets and inventory damaged due to fire, equivalent amount of the assets and inventory impaired is accounted as insurance claim receivables. The final impact shall be given effect to based on the final assessment done in the future. [4] The Board of directors have recommended an interim dividend of INR 0.60 @ 6% per equity share of face value of INR 10/- each. [5] The figures of the previous period have been re-grouped/ rearranged and / or recasted wherever considered necessary. Single segment 2022-04-01 2022-12-31 Unaudited Consolidated 11126306000.00 -63814000.00 11062492000.00 5466555000.00 0.00 -789544000.00 524650000.00 423994000.00 525552000.00 2877117000.00 9028324000.00 2034168000.00 0.00 2034168000.00 453733000.00 153109000.00 606842000.00 0.00 1427326000.00 0.00 0.00 0.00 14748000.00 1442074000.00 -16137000.00 1425937000.00 1241688000.00 200386000.00 1226139000.00 199798000.00 1072068000.00 10 14.07 14.03 0.00 0.00 14.07 14.03 Other Expenses 923674000.00 Other Expenses 2877117000.00